Randomized trials - Ivermectin repurposing for COVID-19 treatment of outpatients with mild disease in primary health care centers. Research, Society and Development, [S. l.], v. 11, n. 8, p. e35511830844, 2022. DOI: 10.33448/rsd-v11i8.30844. Disponível em: https://rsdjournal.org/rsd/article/view/30844. Acesso em: 5 dec. 2025.